TrialDiabetes, obesity & metabolism2025

Dapagliflozin reduces epicardial adipose tissue in patients with heart failure and type 2 diabetes.

Mohmmad Alghamdi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.